Xuli Wang

Simultaneously inactivating Src and AKT by saracatinib/capivasertib co-delivery nanoparticles to improve the efficacy of anti-Src therapy in head and neck squamous cell carcinoma

Yong Teng, Chloe Shay, Yong Teng, 2019, Journal of Hematology & Oncology.